Revvity/$RVTY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Revvity

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Ticker

$RVTY

Primary listing

NYSE

Industry

Life Sciences Tools & Services

Employees

11,000

ISIN

US7140461093

Revvity Metrics

BasicAdvanced
$11B
40.17
$2.35
1.02
$0.28
0.30%

What the Analysts think about Revvity

Analyst ratings (Buy, Hold, Sell) for Revvity stock.

Bulls say / Bears say

Revvity exceeded Wall Street expectations in Q1 2025, reporting an adjusted profit of $1.01 per share and revenue of $664.8 million, driven by steady demand from biotech clients for its medical equipment. (reuters.com)
Barclays raised its price target for Revvity to $140.00 in February 2025, indicating confidence in the company's growth prospects. (etfdailynews.com)
B of A Securities upgraded Revvity's rating from Neutral to Buy in December 2024, reflecting a positive outlook on the company's performance. (nasdaq.com)
In October 2023, Revvity reported Q3 FY23 results below expectations, with revenue declining to $671 million from $712 million year-over-year, leading to a 17% drop in share price. (benzinga.com)
Sanford C. Bernstein downgraded Revvity to Market Perform in January 2025, suggesting concerns about the company's future performance. (americanbankingnews.com)
Barclays lowered its price target for Revvity to $110.00 in April 2025, indicating potential challenges ahead for the company. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

Revvity Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Revvity Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RVTY

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jul18
Revvity
Dividend·Ex-dividend
Aug8
Revvity
Dividend·Payment
$0.07Per share
FAQs